Autek China Inc. (SHE:300595)

China · Delayed Price · Currency is CNY

10.02

+0.07 (0.70%)

Sep 14, 2026, 3:04 PM CST

Market Cap	8.97B -43.6%
Revenue (ttm)	1.86B +3.0%
Net Income	461.41M -7.3%
EPS	0.52 -7.0%
Shares Out	895.29M
PE Ratio	19.36
Forward PE	18.83
Dividend	0.15 (1.38%)
Ex-Dividend Date	May 20, 2026

Volume	8,435,419
Open	9.85
Previous Close	9.95
Day's Range	9.82 - 10.06
52-Week Range	9.86 - 18.27
Beta	0.54
Analysts	Hold
Price Target	13.35 (+33.23%)
Earnings Date	Aug 29, 2026

About Autek China

Autek China Inc. engages in the research and development, production, and sale of optometry products and related supporting products in China. The company offers rigid contact lenses, rigid lens care products, myopia control products other than rigid glasses, visual function training products, dry eye/eye strain/presbyopia/accommodative hypoplasia treatment products, and eye health products. It also provides ophthalmic and optometry medical devices. Autek China Inc. was incorporated in 2000 and is based in Hefei, China. [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 2000

Employees 3,752

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300595

Full Company Profile

Financial Performance

In 2025, Autek China's revenue was 1.86 billion, an increase of 2.62% compared to the previous year's 1.81 billion. Earnings were 479.52 million, a decrease of -16.20%.

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for 300595 stock is "Hold." The 12-month stock price target is ¥13.35, which is an increase of 33.23% from the latest price.

Price Target

¥13.35

(33.23% upside)

Analyst Consensus: Hold

Stock Forecasts